ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Targeted Therapies Transform A.T.T.R.-C.M. Outcomes 10/01/25"
Episode Synopsis
Welcome to Cardiology Today – Recorded October 01, 2025. This episode summarizes 5 key cardiology studies on topics like diagnostic imaging and Cardiovascular health score. Key takeaway: Targeted Therapies Transform A.T.T.R.-C.M. Outcomes.
Article Links:
Article 1: Central Adiposity or Hypertension: Which Drives Heart Failure With a Preserved Ejection Fraction? (Journal of the American College of Cardiology)
Article 2: Transthyretin amyloid cardiomyopathy: from cause to novel treatments. (European heart journal)
Article 3: Polygenic Susceptibility in Peripartum, Alcohol-Induced, and Cancer Therapy-Related Cardiomyopathies. (JAMA cardiology)
Article 4: Cumulative Cardiovascular Health Score Through Young Adulthood and Cardiovascular and Kidney Outcomes in Midlife. (JAMA cardiology)
Article 5: A Deep Learning Model to Identify Mitral Valve Prolapse From the Echocardiogram. (JACC. Cardiovascular imaging)
Full episode page: https://podcast.explainheart.com/podcast/targeted-therapies-transform-a-t-t-r-c-m-outcomes-10-01-25/
Featured Articles
Article 1: Central Adiposity or Hypertension: Which Drives Heart Failure With a Preserved Ejection Fraction?
Journal: Journal of the American College of Cardiology
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41031977
Summary: Article number one. Central Adiposity or Hypertension: Which Drives Heart Failure With a Preserved Ejection Fraction?
Article 2: Transthyretin amyloid cardiomyopathy: from cause to novel treatments.
Journal: European heart journal
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41030053
Summary: Article number two. Transthyretin amyloid cardiomyopathy: from cause to novel treatments.
Article 3: Polygenic Susceptibility in Peripartum, Alcohol-Induced, and Cancer Therapy-Related Cardiomyopathies.
Journal: JAMA cardiology
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41032333
Summary: Article number three. Polygenic Susceptibility in Peripartum, Alcohol-Induced, and Cancer Therapy-Related Cardiomyopathies.
Article 4: Cumulative Cardiovascular Health Score Through Young Adulthood and Cardiovascular and Kidney Outcomes in Midlife.
Journal: JAMA cardiology
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41032326
Summary: Article number four. Cumulative Cardiovascular Health Score Through Young Adulthood and Cardiovascular and Kidney Outcomes in Midlife.
Article 5: A Deep Learning Model to Identify Mitral Valve Prolapse From the Echocardiogram.
Journal: JACC. Cardiovascular imaging
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41031982
Summary: Article number five. A Deep Learning Model to Identify Mitral Valve Prolapse From the Echocardiogram.
Transcript
Today’s date is October 01, 2025. Welcome to Cardiology Today. Here are the latest research findings.
Article number one. Central Adiposity or Hypertension: Which Drives Heart Failure With a Preserved Ejection Fraction?
Article number two. Transthyretin amyloid cardiomyopathy: from cause to novel treatments.
Article number three. Polygenic Susceptibility in Peripartum, Alcohol-Induced, and Cancer Therapy-Related Cardiomyopathies.
Article number four. Cumulative Cardiovascular Health Score Through Young Adulthood and Cardiovascular and Kidney Outcomes in Midlife.
Article number five. A Deep Learning Model to Identify Mitral Valve Prolapse From the Echocardiogram.
Thank you for listening. Don’t forget to subscribe.
Keywords
diagnostic imaging, Cardiovascular health score, artificial intelligence, Dilated Cardiomyopathy, hypertension, Heart Failure with Preserved Ejection Fraction, Mitral Valve Prolapse, echocardiography, polygenic score, amyloid reduction, A.T.T.R.-C.M., transthyretin stabilizers, waist-to-height ratio, prevention, kidney events, body mass index, tafamidis, peripartum cardiomyopathy, cancer therapy-related cardiomyopathy, midlife cardiovascular disease, young adulthood, central adiposity, Transthyretin amyloid cardiomyopathy, Deep learning, alcohol-induced cardiomyopathy.
About
Concise summaries of cardiovascular research for professionals.
Subscribe • Share • FollowThe post Targeted Therapies Transform A.T.T.R.-C.M. Outcomes 10/01/25 first appeared on Cardiology Today.
Article Links:
Article 1: Central Adiposity or Hypertension: Which Drives Heart Failure With a Preserved Ejection Fraction? (Journal of the American College of Cardiology)
Article 2: Transthyretin amyloid cardiomyopathy: from cause to novel treatments. (European heart journal)
Article 3: Polygenic Susceptibility in Peripartum, Alcohol-Induced, and Cancer Therapy-Related Cardiomyopathies. (JAMA cardiology)
Article 4: Cumulative Cardiovascular Health Score Through Young Adulthood and Cardiovascular and Kidney Outcomes in Midlife. (JAMA cardiology)
Article 5: A Deep Learning Model to Identify Mitral Valve Prolapse From the Echocardiogram. (JACC. Cardiovascular imaging)
Full episode page: https://podcast.explainheart.com/podcast/targeted-therapies-transform-a-t-t-r-c-m-outcomes-10-01-25/
Featured Articles
Article 1: Central Adiposity or Hypertension: Which Drives Heart Failure With a Preserved Ejection Fraction?
Journal: Journal of the American College of Cardiology
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41031977
Summary: Article number one. Central Adiposity or Hypertension: Which Drives Heart Failure With a Preserved Ejection Fraction?
Article 2: Transthyretin amyloid cardiomyopathy: from cause to novel treatments.
Journal: European heart journal
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41030053
Summary: Article number two. Transthyretin amyloid cardiomyopathy: from cause to novel treatments.
Article 3: Polygenic Susceptibility in Peripartum, Alcohol-Induced, and Cancer Therapy-Related Cardiomyopathies.
Journal: JAMA cardiology
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41032333
Summary: Article number three. Polygenic Susceptibility in Peripartum, Alcohol-Induced, and Cancer Therapy-Related Cardiomyopathies.
Article 4: Cumulative Cardiovascular Health Score Through Young Adulthood and Cardiovascular and Kidney Outcomes in Midlife.
Journal: JAMA cardiology
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41032326
Summary: Article number four. Cumulative Cardiovascular Health Score Through Young Adulthood and Cardiovascular and Kidney Outcomes in Midlife.
Article 5: A Deep Learning Model to Identify Mitral Valve Prolapse From the Echocardiogram.
Journal: JACC. Cardiovascular imaging
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41031982
Summary: Article number five. A Deep Learning Model to Identify Mitral Valve Prolapse From the Echocardiogram.
Transcript
Today’s date is October 01, 2025. Welcome to Cardiology Today. Here are the latest research findings.
Article number one. Central Adiposity or Hypertension: Which Drives Heart Failure With a Preserved Ejection Fraction?
Article number two. Transthyretin amyloid cardiomyopathy: from cause to novel treatments.
Article number three. Polygenic Susceptibility in Peripartum, Alcohol-Induced, and Cancer Therapy-Related Cardiomyopathies.
Article number four. Cumulative Cardiovascular Health Score Through Young Adulthood and Cardiovascular and Kidney Outcomes in Midlife.
Article number five. A Deep Learning Model to Identify Mitral Valve Prolapse From the Echocardiogram.
Thank you for listening. Don’t forget to subscribe.
Keywords
diagnostic imaging, Cardiovascular health score, artificial intelligence, Dilated Cardiomyopathy, hypertension, Heart Failure with Preserved Ejection Fraction, Mitral Valve Prolapse, echocardiography, polygenic score, amyloid reduction, A.T.T.R.-C.M., transthyretin stabilizers, waist-to-height ratio, prevention, kidney events, body mass index, tafamidis, peripartum cardiomyopathy, cancer therapy-related cardiomyopathy, midlife cardiovascular disease, young adulthood, central adiposity, Transthyretin amyloid cardiomyopathy, Deep learning, alcohol-induced cardiomyopathy.
About
Concise summaries of cardiovascular research for professionals.
Subscribe • Share • FollowThe post Targeted Therapies Transform A.T.T.R.-C.M. Outcomes 10/01/25 first appeared on Cardiology Today.
More episodes of the podcast Cardiology Today
CRISPR-Cas9 Gene Editing for Lipids 11/11/25
11/11/2025
In God we trust